Topic

New Jersey

A collection of 505 issues

Getting Adynovate (Antihemophilic Factor VIII) Covered by Blue Cross Blue Shield in New Jersey: Complete Prior Authorization and Appeals Guide

Answer Box: Fast Track to Adynovate Coverage Adynovate (antihemophilic factor VIII, pegylated) requires prior authorization from Blue Cross Blue Shield in New Jersey. Submit PA through your plan's Medical Injectables Program with hemophilia A diagnosis, factor levels, bleeding history, and prophylaxis rationale. If denied, you have 180 days
6 min read

Getting Rystiggo (rozanolixizumab-noli) Covered by Blue Cross Blue Shield in New Jersey: Complete Coding, Prior Authorization, and Appeals Guide

Answer Box: Your Path to Rystiggo Coverage in New Jersey Rystiggo (rozanolixizumab-noli) requires prior authorization from Blue Cross Blue Shield in New Jersey for generalized myasthenia gravis patients who are AChR or MuSK antibody positive. First step: Confirm if your plan covers it under medical benefit (J9333 billing) or specialty
5 min read